Delivery Order SPE2DB22D1103-SPE2DB24FTJB8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The delivery order, valued at $7,029.64, is for the supply of Eliquis 5 mg tablets. The contract is a firm fixed price arrangement with an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Eliquis 5 mg tablets. The contract, valued at $17,951.80, is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $10,226.55 and an ultimate completion date of May 21, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, as a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The $2,783.42 firm fixed-price delivery order has a completion date of February 7, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The $5,103.25 firm fixed-price delivery order has a completion date of July 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Eliquis 5 mg tablets. The contract has a total ceiling value of $16,082.49 and a period of performance through April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is for the delivery of the pharmaceutical product Eliquis 5 mg tablets to the U.S. Department of Defense. The award has a ceiling value of $48,210.46 and a completion date of March 26, 2024. It is a firm fixed price delivery order contract, with no set-aside designation used. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $14,668.57 for the delivery of Eliquis 5 mg tablets. The contract is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 17, 2024 and does not include a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,529.23 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of August 20, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Eliquis 5 mg tablets. The $7,018.95 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of July 2, 2024. The contract is not set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTJB8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $7,723.75 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 4/15/24 |